Watchlist Manager

Watchlist

Price: 1.004 USD Market Closed

Market Cap: $758.4m

C	China Shineway Pharmaceutical Group Ltd OTC:CSWYF	CN

Balance Sheet

Currency: CNY

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	339	295	1 147	1 348	1 582	1 678	1 586	2 318	2 007	2 076	2 212	2 292	2 688	2 826	3 218	3 532	3 611	3 946	3 943	4 206	5 026	5 889	6 140	7 189
Cash	339	295	1 147	1 348	1 582	1 678	1 586	2 318	2 007	2 076	2 212	2 292	2 688	2 826	3 218	3 532	3 611	3 946	3 943	4 206	5 026	5 889	6 140	7 189
Short-Term Investments	0	0	0	0	0	0	0	0	342	96	0	0	0	0	0	0	0	0	0	0	20	20	350	377
Total Receivables	188	93	195	138	67	254	309	82	271	418	522	680	594	459	555	533	532	674	761	825	975	1 260	1 202	1 000
Accounts Receivables	127	36	8	3	3	9	11	6	7	13	20	10	13	31	51	72	174	260	312	424	673	758	908	806
Other Receivables	61	57	187	135	63	245	298	76	264	404	501	670	581	428	504	461	358	414	449	401	302	502	294	194
Inventory	38	46	18	36	38	78	76	136	192	283	204	245	286	341	294	280	405	431	443	588	658	898	813	691
Other Current Assets	2	5	12	18	23	34	43	149	130	126	124	661	382	214	183	215	104	152	372	80	103	88	93	47
Total Current Assets	567	440	1 371	1 538	1 710	2 045	2 014	2 685	2 941	2 999	3 061	3 877	3 950	3 840	4 251	4 560	4 653	5 203	5 519	5 699	6 782	8 155	8 599	9 304
PP&E Net	188	191	180	231	224	279	326	457	777	1 108	1 398	1 599	1 575	1 529	1 466	1 402	1 404	1 494	1 395	1 252	1 217	1 205	1 219	1 249
PP&E Gross	188	191	180	231	224	279	326	457	777	1 108	1 398	1 599	1 575	1 529	1 466	1 402	1 404	1 494	1 395	1 252	1 217	1 205	1 219	0
Accumulated Depreciation	44	65	87	112	142	174	208	252	304	368	443	538	676	815	959	1 101	1 239	1 398	1 566	1 655	1 807	1 903	1 996	0
Intangible Assets	0	0	0	0	0	0	0	0	2	1	1	1	23	389	348	308	288	248	37	66	47	33	23	16
Goodwill	0	0	0	59	59	59	59	59	92	92	92	92	100	159	159	159	159	159	102	166	166	166	166	166
Long-Term Investments	0	0	0	0	0	0	0	0	0	0	17	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	2	0	20	17	15	27	28	70	160	176	174	170	260	236	240	236	228	27	160	20	19	15	34	43
Other Assets	0	0	0	59	59	59	59	59	92	92	92	92	100	159	159	159	159	159	102	166	166	166	166	166
Total Assets	756 N/A	631 -17%	1 570 +149%	1 845 +17%	2 008 +9%	2 409 +20%	2 427 +1%	3 270 +35%	3 972 +21%	4 377 +10%	4 743 +8%	5 738 +21%	5 907 +3%	6 153 +4%	6 465 +5%	6 665 +3%	6 732 +1%	7 131 +6%	7 214 +1%	7 204 0%	8 232 +14%	9 574 +16%	10 042 +5%	10 777 +7%
Liabilities
Accounts Payable	112	40	33	58	76	89	64	225	203	290	275	220	202	224	219	231	213	189	164	229	309	485	403	340
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	500	200	0	0	0	0	398	369	0	0	300	330	325
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	8	8	7	1	8	9
Other Current Liabilities	83	81	99	157	162	250	226	323	464	357	380	460	483	477	454	479	567	586	653	862	1 350	1 648	1 709	1 836
Total Current Liabilities	195	121	132	215	239	340	290	548	667	646	655	1 180	886	702	673	709	780	1 178	1 195	1 098	1 666	2 434	2 450	2 510
Long-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	15	7	1	0	8	0
Deferred Income Tax	3	6	0	0	0	0	0	0	1	1	1	29	24	63	56	61	61	47	5	25	19	16	35	0
Minority Interest	30	64	24	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	226	45	2	0	0	0	0	0	75	75	90	100	105	93	109	74	125	128	204	172	164	89	82	205
Total Liabilities	454 N/A	235 -48%	158 -33%	215 +36%	239 +11%	340 +42%	290 -15%	548 +89%	743 +36%	723 -3%	747 +3%	1 309 +75%	1 015 -22%	857 -16%	839 -2%	844 +1%	966 +14%	1 354 +40%	1 419 +5%	1 302 -8%	1 849 +42%	2 539 +37%	2 575 +1%	2 715 +5%
Equity
Common Stock	0	0	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88	88
Retained Earnings	302	396	342	581	732	1 032	1 067	1 652	2 160	2 584	3 141	3 574	4 037	4 441	4 772	5 140	5 560	5 815	5 869	5 970	6 451	7 104	7 536	7 974
Additional Paid In Capital	0	0	982	982	982	982	982	982	982	982	767	767	767	767	767	594	422	422	422	422	422	422	422	0
Other Equity	0	0	0	21	33	33	0	0	0	0	0	0	0	0	0	0	304	548	585	579	579	579	579	0
Total Equity	302 N/A	396 +31%	1 413 +257%	1 630 +15%	1 769 +9%	2 069 +17%	2 137 +3%	2 722 +27%	3 230 +19%	3 654 +13%	3 996 +9%	4 429 +11%	4 892 +10%	5 296 +8%	5 627 +6%	5 821 +3%	5 766 -1%	5 777 +0%	5 794 +0%	5 901 +2%	6 383 +8%	7 035 +10%	7 467 +6%	8 062 +8%
Total Liabilities & Equity	756 N/A	631 -17%	1 570 +149%	1 845 +17%	2 008 +9%	2 409 +20%	2 427 +1%	3 270 +35%	3 972 +21%	4 377 +10%	4 743 +8%	5 738 +21%	5 907 +3%	6 153 +4%	6 465 +5%	6 665 +3%	6 732 +1%	7 131 +6%	7 214 +1%	7 204 0%	8 232 +14%	9 574 +16%	10 042 +5%	10 777 +7%
Shares Outstanding
Common Shares Outstanding	600	600	830	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827	827

Income Statement Balance Sheet Cash Flow Statement

China Shineway Pharmaceutical Group Ltd
OTC:CSWYF

Balance Sheet

Balance Sheet Decomposition
China Shineway Pharmaceutical Group Ltd

Balance Sheet
China Shineway Pharmaceutical Group Ltd

See Also

Company

Help

Tools

Stocks

China Shineway Pharmaceutical Group Ltd OTC:CSWYF

Balance Sheet

Balance Sheet Decomposition China Shineway Pharmaceutical Group Ltd

Balance Sheet China Shineway Pharmaceutical Group Ltd

See Also

Company

Help

Tools

Stocks

China Shineway Pharmaceutical Group Ltd
OTC:CSWYF

Balance Sheet Decomposition
China Shineway Pharmaceutical Group Ltd

Balance Sheet
China Shineway Pharmaceutical Group Ltd